Conservative Sample Size Estimation in Nonparametrics
- 20 December 2010
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 21 (1) , 24-41
Abstract
Due to the uncertainty of the results of phase II trials, underpowered phase III trials are often planned. In recent literature the conservative approach for sample size estimation was proposed. Some authors, in the parametric framework, make use of the lower bound of the effect size for conservatively estimating the true power, and so the sample sizes. Here, we present a general bootstrap method for conservatively estimating, on the basis of phase II data, the sample size needed for a phase III trial. The method we propose is based on the use of nonparametric lower bounds for the true power of the test. A wide study is shown for comparing the performances of the new method in estimating the power of the Wilcoxon rank-sum test with those given by standard techniques based on the asymptotic normality of the test statistic. Results indicate that when the phase II sample size is around the ideal sample size for the phase III, the bootstrap provides better results than the other techniques. Since the method is general, it could be used for planning clinical trials for testing superiority, for testing noninferiority, and for more complicated situations, e.g., for testing multiple endpoints.Keywords
This publication has 19 references indexed in Scilit:
- Sample size calculation for the Wilcoxon–Mann–Whitney test adjusting for tiesStatistics in Medicine, 2007
- Accounting for Variability in Sample Size Estimation with Applications to Nonadherence and Estimation of Variance and Effect SizeBiometrics, 2006
- Challenge of multiple co‐primary endpoints: a new approachStatistics in Medicine, 2006
- Sample size and the probability of a successful trialPharmaceutical Statistics, 2006
- Adapting the sample size planning of a phase III trial based on phase II dataPharmaceutical Statistics, 2006
- Confidence intervals for an effect size measure based on the Mann–Whitney statistic. Part 2: asymptotic methods and evaluationStatistics in Medicine, 2005
- A nonparametric test for proving noninferiority in clinical trials with ordered categorical dataPharmaceutical Statistics, 2003
- On the Bootstrap of $U$ and $V$ StatisticsThe Annals of Statistics, 1992
- Sample Size Determination for Some Common Nonparametric TestsJournal of the American Statistical Association, 1987
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978